Aytu BioPharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Aytu BioPharma Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- AYTU
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001385818
Board of directors
-
Abhinav Jain · DirectorSince 2023
-
Carl Dockery · DirectorSince 2023
-
John Donofrio Jr. · DirectorSince 2023
-
Joshua R. Disbrow · Director · Chief Executive OfficerSince 2023
-
Vivian H. Liu · DirectorSince 2023
Chief executives
Joshua R. Disbrow
· Chief Executive Officer
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Abhinav Jain
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2025 | PYSZCZYMUKA GREG Officer (Chief Commercial Officer) | Option exercise | +209 | — | — |
| Feb 28, 2025 | Joshua R. Disbrow Officer (Chief Executive Officer) | Open-market purchase | +15,000 | $1.30 | $19,500 |
| Feb 5, 2025 | Selhorn Ryan J Officer (Chief Financial Officer) | Option exercise | +105 | — | — |
| Dec 31, 2024 | PYSZCZYMUKA GREG Officer (Chief Commercial Officer) | Option exercise | +208 | — | — |
| Nov 11, 2024 | Selhorn Ryan J Officer (Chief Financial Officer) | Grant or award | +14,000 | — | — |
| Nov 6, 2024 | Carl Dockery Director | Grant or award | +1,500 | — | — |
| Nov 6, 2024 | John Donofrio Jr. Director | Grant or award | +1,500 | — | — |
| Nov 6, 2024 | Abhinav Jain Director | Grant or award | +1,500 | — | — |
| Nov 6, 2024 | Vivian H. Liu Director | Grant or award | +1,500 | — | — |
| Sep 30, 2024 | PYSZCZYMUKA GREG Officer (Chief Commercial Officer) | Option exercise | +209 | — | — |
| Jun 30, 2024 | PYSZCZYMUKA GREG Officer (Chief Commercial Officer) | Option exercise | +208 | — | — |
| Mar 31, 2024 | PYSZCZYMUKA GREG Officer (Chief Commercial Officer) | Option exercise | +208 | — | — |
| Dec 31, 2023 | PYSZCZYMUKA GREG Officer (Chief Commercial Officer) | Option exercise | +209 | — | — |
| Sep 30, 2023 | PYSZCZYMUKA GREG Officer (Chief Commercial Officer) | Option exercise | +208 | — | — |
| Aug 16, 2023 | Abhinav Jain Director | Grant or award | +6,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.